Clinical and Translational Science Collaborative of Northern Ohio’s Post

Great to see this topic rising to the top at the ACTS Conference this week. #TS24Vegas “Creating a Process to Develop Social Responsibility Best Practices in Translational Science —Public acceptance and successful implementation of translational interventions depends upon thoughtful consideration and alignment with the values, opportunities, and needs of patients and communities.” Clinical and Translational Science Collaborative of Northern Ohio

Wright Center Director of Evaluation Dr. Deborah DiazGranados and her colleague Dr. Clara M. Pelfrey Director of Evaluation at the Case Western CTSA are leading a national CTSA workgroup focused on Learning about the Science of Translation. The workgroup will conduct a comparative analysis of many kinds of successful translational science case studies. The purpose of this collaboration is to generate new knowledge about the nature of the translational process by investigating and comparing successful translational science cases that have led to positive impacts on human health. #translationalscience #ctsaprogram

Important work - invaluable to tease out similarities and differences for different types of healthcare innovation

**Exploring the Future of Precision Medicine with Dr. Mark Kristiansen ** This is a secret I have kept for a while 👀👀👀 I had the privilege of interviewing Dr. Mark Kristiansen, the Head of Genomics at the Zayed Centre for Research into Rare Disease in Children (ZCR), UCL half a year ago, during which we delved into the future of precision medicine, its challenges, and how we can address them. In our discussion, Dr. Kristiansen emphasized the importance of public engagement in personalized medicine - the need for transparency and openness in scientific work, which is embodied in the 'fish tank' design of the ZCR lab. He also touched on the challenges posed by the diverse nature of personalized medicine and the danger of false information, stressing the importance of truthful communication to maintain public trust and the need for a tailored education strategy in different contexts. Lastly, he underscored the role of healthcare providers in informing patients about novel therapies and the need for government involvement in integrating personalized medicine into traditional clinical trials and approval systems. Nevertheless, we both agreed that the future of personalised medicine is optimistic, but the road to a better future is always an uphill climb. I would like to express my gratitude to Dr. Mark Kristiansen for his insightful thoughts and to the editor for making this article possible. You can now view my article on https://lnkd.in/g7j3ydjJ #PrecisionMedicine #Genomics #HealthcareInnovation #PublicEngagement

📢 #NYValves2024 Call for Science Deadline has been extended to April 16 at 2:00 PM EDT (UTC −4)! 🚨 Submit your research in any of these four categories for the chance to join the esteemed faculty. ✨Moderated Abstracts ✨Challenging Cases ✨Innovation ✨Late-Breaking Clinical Science and First-in-Human & Early Feasibility Studies https://ow.ly/UwWe50R9voh #interventionalcardiology

A date for the diary! Can we design research so that it improves the world we live in? That is what translational research does. This session, co-designed by Taylor & Francis Group, brings together translational research experts from Science, Medicine, Social Science, Engineering to look at how research can be conducted in a way that supports positive, practical outcomes that solve challenges. #TranslationalResearch, #ResearchImpact, #ResearchPolicy

We’re excited to be part of the Future Medicine Innovation Days in Berlin! This new science conference by Verlag Der Tagesspiegel brings together leaders in research and healthcare to explore innovative ideas that will shape tomorrow’s medicine. Our Scientific Director, Maike Sander, participated in a panel on “Innovation through Collaboration,” alongside Søren Salomo (TU Berlin) and Matthias Meergans (VFA), moderated by Stephan-Andreas Casdorff. Together, they discussed the essential connections between science and industry. Thanks all for the inspiring exchange! Maike Sander highlighted key areas to strengthen innovation and translation: ✅ Foster greater interaction between academia, biotech, and pharma. ✅ Create educational programs for MDs and PhDs to gain industry experience. ✅ Diversify PhD tracks to include paths for entrepreneurship and translation. ✅ Reform academic research assessments to recognize varied research contributions. Watch the replay if you missed the event: 👉 https://lnkd.in/eBzBRvRf 👈 At the Max Delbrück Center, we’re committed to fostering collaboration and paving the way for discoveries that will define tomorrow’s medicine. #FutureMedicine #Innovation #LifeSciences #ResearchAndDevelopment #HealthcareInnovation #mdcBerlin

Achieving representative clinical trials in the U.S. requires coordinated and concerted action. ACRP recognizes the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center), Clinical Trials Transformation Initiative (CTTI), Milken Institute, and The National Academies of Sciences, Engineering, and Medicine for leading the development of a national action plan to inform and inspire system-level change in improving representation in clinical trials. Learn more in the MRCT Center's framework, "Toward a National Action Plan for Achieving Diversity in Clinical Trials" > https://bit.ly/3YAOOyO

Yes! Our LEO Foundation Center’s strategic review has been approved.   Professor Martin Malmsten, Research Director and Principal Investigator of LEO Foundation Center for Cutaneous Drug Delivery (LFCCDD), says: “This favourable and constructive review reassures us that the center is doing well and has great potential for further development. As a leader, I am both pleased and very proud.”   LFCCDD https://lnkd.in/ejJjTR6y at Department of Pharmacy, University of Copenhagen was subject to a strategic review in November by an international panel of experts, resulting in a report that recently was discussed and now approved by the LEO Foundation // LEO Fondet.   👨🔬 👩🔬 The panel was: Chair Professor Calum Drummond AO from RMIT University, Professor Marjana Tomic-Canic, University of Miami, Professor Ryan Donnelly, Queen's University Belfast and Associate Professor Pankaj Karande from Rensselaer Polytechnic Institute. They spent two days in Copenhagen where they met the center staff, Head of Department Jukka Rantanen and LEO Foundation // LEO Fondet representatives. Thank you all for two intensive days. So, what’s the short version of the panel’s report? Check it out: 1️⃣ 👉🏼 Key strengths of LFCCDD Overall, the panel is very happy with the development of the center and notes an excellent track record regarding publications and external funding. It also highlights the cohesive center construction, exemplary leadership, good mentoring, an enabling culture, and committed staff, and that individual projects share a common tread, enabling joint themes.   2️⃣ 👉🏼 LFCCDD opportunities Furthermore, the panel notes the proximity to the large-scale facilities MAX IV Laboratory and European Spallation Source ERIC as a competitive advantage for the center. Based on these considerations, the panel sees opportunities for the center to intensity its international ambitions regarding both funding and collaborations, as well as to further develop translational activities and the position of the center within the Faculty of Health and Medical Sciences, UCPH at the University of Copenhagen.   3️⃣ 👉🏼 Recommendations for future development of LFCCDD In addition, the panel recommends some aspects to be considered in the continued development of the center, including the teaching load of center staff, laboratory space, and strategies for future funding of the center. #pharmacy #skindiseases #skinresearch #dkforsk #kbhuni

Check out this impactful upcoming policy meeting (BTMS) where my colleague Dr. Adriana Bankston will be dropping some knowledge!